Gulf study tests which blood thinner best protects hearts

NCT ID NCT07572747

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two common blood thinners, aspirin and clopidogrel, to see which one better prevents heart attacks, strokes, and related events in people with stable heart disease. About 6,740 participants from Gulf countries will take one of the two drugs for several years. The goal is to find the most effective long-term prevention strategy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Aspirin and clopidogrel

What this could lead to

If successful, this could show that clopidogrel is better than aspirin at preventing heart attacks and strokes in people with stable heart disease.

What could go wrong

This is a large phase 3 trial, but it hasn't started yet. Results may not apply to all patients, and both drugs carry bleeding risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••